4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-007295
Senior VP - Drug Discovery gave up 22,431 shares (to pay taxes)
- Senior VP - Drug Discovery acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-19 | Exercise or conversion : show line 1 in the form | +50,000 | $4.15 | $207,500 | 205,587 | D |
| 2021-02-19 | Shares withheld for taxes : show line 2 in the form | −22,431 | $11.53 | $258,629 | 183,156 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-19 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −50,000 | 0 | D |
Loading xslF345X03/form4.xml…